Ishita Drugs & Industries: Ishita Drugs Reappoints Abha Agrawal After Age 75, Renews Auditor Term
Ishita Drugs shareholders approved Abha Agrawal’s reappointment after age 75 and renewed the statutory auditor’s term, with appointments effective October 1.

Ishita Drugs reappoints Abha Agrawal as a Non-Executive Non-Independent Director after she attained the age of 75 and renews its statutory auditor’s appointment, according to the company’s October 2, 2026 BSE filing. Both appointments carry an effective date of October 1, 2026 in the accompanying disclosures.
Shareholders approved the resolutions at the company’s 33rd Annual General Meeting held on September 30, 2026. The voting results were declared on October 2. The company said the approvals followed recommendations from its Nomination and Remuneration Committee and Board of Directors.
The disclosure, submitted under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, covers two reappointments at the company, which trades on BSE under scrip code 524400.
Abha Agrawal continues in non-executive role
Agrawal, whose Director Identification Number is 01589479, retired by rotation and offered herself for reappointment. Shareholders approved her continuation as a Non-Executive Non-Independent Director after attaining 75 years.
According to the filing, she is a promoter and has been associated with Ishita Drugs since its inception. Her profile describes more than 30 years of independently running business operations in chemicals, electrical switches and circuit breakers, alongside extensive experience in business matters.
The company disclosed that she is the spouse of Managing Director Jagdish Agrawal and has no relationship with any other director. It also declared that she is not debarred from holding a directorship by any SEBI order or other authority.
Statutory auditor’s appointment renewed
Shareholders also approved the reappointment of Jaymin Shah & Associates, Chartered Accountants, as statutory auditor. The firm’s registration number is 129406W. The filing sets out the appointment terms as follows:
- The auditor will hold office from the conclusion of the 33rd AGM until the conclusion of the 34th AGM.
- The annexure records October 1, 2026 as the appointment date and describes a one-year term commencing from that date.
The firm’s disclosed services include audit, management and tax consultancy, corporate compliance, accounting, financial services and GST consultation. Its profile also lists direct and indirect tax appeals and cross-border practice.
